TRCT
AEMD icon

Tower Research Capital (TRC)’s Aethlon Medical AEMD Stock Holding History

Tower Research Capital (TRC)’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.21K Buy
1,266
+944
+293% +$9.78K ﹤0.01% 4296
2026
Q1 		$3.53K Buy
+322
New +$3.66K ﹤0.01% 4304
2025
Q4 		– Sell
-60
Closed -$2.24K – 5117
2025
Q3 		$2.24K Buy
60
+46
+329% +$2.65K ﹤0.01% 4665
2025
Q2 		$848 Buy
+14
New +$1.88K ﹤0.01% 4928
2025
Q1 		– Sell
-10
Closed -$2.33K – 5106
2024
Q4 		$3.29K Sell
10
-10
-50% -$1.7K ﹤0.01% 4676
2024
Q3 		$3.68K Buy
20
+3
+18% +$477 ﹤0.01% 4798
2024
Q2 		$3.44K Buy
17
+14
+467% +$5.52K ﹤0.01% 4889
2024
Q1 		$1.91K Hold
3
– – ﹤0.01% 5156
2023
Q4 		$2.37K Buy
3
+1
+50% +$711 ﹤0.01% 5229
2023
Q3 		$1.93K Hold
2
– – ﹤0.01% 5239
2023
Q2 		$3.07K Hold
2
– – ﹤0.01% 5117
2023
Q1 		$3K Hold
2
– – ﹤0.01% 5164
2022
Q4 		$2K Hold
2
– – ﹤0.01% 5317
2022
Q3 		$5K Buy
2
+1
+100% +$4.33K ﹤0.01% 5117
2022
Q2 		$4K Hold
1
– – ﹤0.01% 5160
2022
Q1 		$8K Buy
+1
New +$5.97K ﹤0.01% 4548
2021
Q4 		– Hold
0
– – – 5591
2021
Q3 		– Sell
-4
Closed -$67.2K – 5071
2021
Q2 		$72K Buy
+4
New +$46.1K ﹤0.01% 2696
2021
Q1 		– Hold
0
– – – 5356
2016
Q4 		– Hold
0
– -$3K – 3776
2016
Q3 		– Hold
0
– – – 2805
2016
Q2 		– Hold
0
– -$5K – 4376
2016
Q1 		– Hold
0
– – – 2646
2015
Q4 		– Hold
0
– – – 3674
2015
Q3 		– Hold
0
– – – 3555

Other funds holding AEMD

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tower Research Capital (TRC)'s AEMD Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Aethlon Medical (AEMD) stake by 293% in Q2 2026, buying an estimated $9.78K and bringing the position to 1,266 shares worth $5.21K. The position accounts for ﹤0.01% of the portfolio, ranked #4296.

Tower Research Capital (TRC) first reported a position in AEMD in Q2 2021 and has held it in 17 quarters since. The position peaked at $72K in Q2 2021. 15 funds tracked by Wall St. Rank hold AEMD as of Q2 2026.

  • Tower Research Capital (TRC) held 1,266 shares of Aethlon Medical worth $5.21K as of Q2 2026.
  • Tower Research Capital (TRC) bought 944 Aethlon Medical shares in Q2 2026, an estimated $9.78K.
  • Aethlon Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4296 holding.
  • Tower Research Capital (TRC) first reported a position in Aethlon Medical in Q2 2021 and has held it in 17 quarters since.
  • Tower Research Capital (TRC)'s Aethlon Medical position peaked at $72K in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.